Antifungal Activity of a Library of Aminothioxanthones

Fungal infections are one of the main causes of mortality and morbidity worldwide and taking into account the increasing incidence of strains resistant to classical antifungal drugs, the development of new agents has become an urgent clinical need. Considering that thioxanthones are bioisosteres of xanthones with known anti-infective actions, their scaffolds were selected for this study. A small library of synthesized aminothioxanthones (1–10) was evaluated for in vitro antifungal activity against Candida albicans, Aspergillus fumigatus, and Trichophyton rubrum; for the active compounds, the spectrum was further extended to other clinically relevant pathogenic fungi. The results showed that only compounds 1, 8, and 9 exhibited inhibitory and broad-spectrum antifungal effects. Given the greater antifungal potential presented, compound 1 was the subject of further investigations to study its anti-virulence activity and in an attempt to elucidate its mechanism of action; compound 1 seems to act predominantly on the cellular membrane of C. albicans ATCC 10231, altering its structural integrity, without binding to ergosterol, while inhibiting two important virulence factors—dimorphic transition and biofilm formation—frequently associated with C. albicans pathogenicity and resistance. In conclusion, the present work proved the usefulness of thioxanthones in antifungal therapy as new models for antifungal agents.

[1]  A. Shiroudi,et al.  Novel 1, 2, 4-Triazoles as Antifungal Agents , 2022, BioMed research international.

[2]  A. Palmeira,et al.  Antimicrobial Activity of a Library of Thioxanthones and Their Potential as Efflux Pump Inhibitors , 2021, Pharmaceuticals.

[3]  L. Saraíva,et al.  Mechanism of Antifungal Activity by 5-Aminoimidazole-4-Carbohydrazonamide Derivatives against Candida albicans and Candida krusei , 2021, Antibiotics.

[4]  F. O. Pereira.  A review of recent research on antifungal agents against dermatophyte biofilms. , 2021, Medical mycology.

[5]  A. Palmeira,et al.  From Natural Products to New Synthetic Small Molecules: A Journey through the World of Xanthones , 2021, Molecules.

[6]  S. de Hoog,et al.  Introduction to Dermatophytes , 2021 .

[7]  E. Sousa,et al.  Marine-Derived Compounds and Prospects for Their Antifungal Application , 2020, Molecules.

[8]  Nizar M. Mhaidat,et al.  Investigation of binding characteristics of Phosphoinositide-dependent kinase-1 (PDK1) co-crystallized ligands through virtual pharmacophore modeling leading to novel anti - PDK1 hits. , 2020, Medicinal chemistry (Shariqah (United Arab Emirates)).

[9]  A. C. D. de Paula,et al.  Phenylpropanoid-based sulfonamide promotes cyclin D1 and cyclin E down-regulation and induces cell cycle arrest at G1/S transition in estrogen positive MCF-7 cell line. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.

[10]  J. Guarner,et al.  Emerging and reemerging fungal infections. , 2019, Seminars in diagnostic pathology.

[11]  E. Sousa,et al.  The Antitumor Activity of a Lead Thioxanthone is Associated with Alterations in Cholesterol Localization , 2018, Molecules.

[12]  Yi Ding,et al.  An insight into new strategies to combat antifungal drug resistance , 2018, Drug design, development and therapy.

[13]  J. Adrio,et al.  Antifungals , 2018, Reactions Weekly.

[14]  E. Sousa,et al.  Lichen Xanthones as Models for New Antifungal Agents , 2018, Molecules.

[15]  So H. Kim,et al.  Imidazole Antifungal Drugs Inhibit the Cell Proliferation and Invasion of Human Breast Cancer Cells , 2018, Biomolecules & therapeutics.

[16]  M. D. S. de Sousa Cartágenes,et al.  Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents , 2018, Front. Microbiol..

[17]  T. Dymerski,et al.  Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils , 2018, Molecules.

[18]  A. Fuentefria,et al.  Antifungals discovery: an insight into new strategies to combat antifungal resistance , 2018, Letters in applied microbiology.

[19]  D. Perlin,et al.  Fungal infections 5 The global problem of antifungal resistance: prevalence, mechanisms, and management , 2017 .

[20]  M. Abdollahi,et al.  Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint , 2017, Critical reviews in microbiology.

[21]  A. Palmeira,et al.  Modulation of Autophagy by a Thioxanthone Decreases the Viability of Melanoma Cells , 2016, Molecules.

[22]  S. Garneau‐Tsodikova,et al.  A complex game of hide and seek: the search for new antifungals. , 2016, MedChemComm.

[23]  M. Jabra-Rizk,et al.  Pathogenesis of Candida albicans biofilm. , 2016, Pathogens and disease.

[24]  A. Palmeira,et al.  Screening a Small Library of Xanthones for Antitumor Activity and Identification of a Hit Compound which Induces Apoptosis , 2016, Molecules.

[25]  J. Lopez-Ribot,et al.  A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance , 2015, npj Biofilms and Microbiomes.

[26]  A. Palmeira,et al.  Synergistic Effects Between Thioxanthones and Oxacillin Against Methicillin-Resistant Staphylococcus aureus. , 2015, Microbial drug resistance.

[27]  J. Barbosa-Filho,et al.  Evaluation of Antifungal Activity and Mode of Action of New Coumarin Derivative, 7-Hydroxy-6-nitro-2H-1-benzopyran-2-one, against Aspergillus spp. , 2015, Evidence-based complementary and alternative medicine : eCAM.

[28]  Philipp Stiefel,et al.  Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide , 2015, BMC Microbiology.

[29]  L. Cowen,et al.  Mechanisms of Antifungal Drug Resistance. , 2015, Cold Spring Harbor perspectives in medicine.

[30]  A. Fuentefria,et al.  Antifungal activity and mechanism of action of monoterpenes against dermatophytes and yeasts , 2014 .

[31]  A. Mitchell,et al.  Fungal biofilms, drug resistance, and recurrent infection. , 2014, Cold Spring Harbor perspectives in medicine.

[32]  E. Lima,et al.  Evaluation of Antifungal Activity and Mechanism of Action of Citral against Candida albicans , 2014, Evidence-based complementary and alternative medicine : eCAM.

[33]  A. Fusco-Almeida,et al.  In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms , 2014, Biofouling.

[34]  Yuquan Wei,et al.  Itraconazole suppresses the growth of glioblastoma through induction of autophagy , 2014, Autophagy.

[35]  Yinglong Hou,et al.  Combination of fluconazole with non-antifungal agents: a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. , 2014, International journal of antimicrobial agents.

[36]  S. Kaur,et al.  Biofilm formation by Aspergillus fumigatus. , 2013, Medical mycology.

[37]  P. Andrade,et al.  Antifungal Activity of Phlorotannins against Dermatophytes and Yeasts: Approaches to the Mechanism of Action and Influence on Candida albicans Virulence Factor , 2013, PloS one.

[38]  Youwei Wang,et al.  Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. , 2013, Journal of medical microbiology.

[39]  E. Sousa,et al.  A century of thioxanthones: through synthesis and biological applications. , 2013, Current medicinal chemistry.

[40]  A. Palmeira,et al.  Dual inhibitors of P-glycoprotein and tumor cell growth: (re)discovering thioxanthones. , 2012, Biochemical pharmacology.

[41]  E. Sousa,et al.  Antifungal Activity of Xanthones: Evaluation of their Effect on Ergosterol Biosynthesis by High‐performance Liquid Chromatography , 2011, Chemical biology & drug design.

[42]  N. Martinez-Rossi,et al.  Dermatophytes: host-pathogen interaction and antifungal resistance. , 2010, Anais brasileiros de dermatologia.

[43]  David W Williams,et al.  Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. , 2009, Medical mycology.

[44]  K. Burgess,et al.  Synthesis and spectroscopic properties of rosamines with cyclic amine substituents. , 2008, The Journal of organic chemistry.

[45]  G. Kirsch,et al.  Antifungal activity of synthetic di(hetero)arylamines based on the benzo[b]thiophene moiety. , 2008, Bioorganic & medicinal chemistry.

[46]  M. Isobe,et al.  Determination of solvent-trapped products obtained by photolysis of aryl azides in 2,2,2-trifluoroethanol. , 2008, Chemistry, an Asian journal.

[47]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[48]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[49]  Craig Williams,et al.  Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. , 2007, Journal of medical microbiology.

[50]  R. Schwartz,et al.  Superficial fungal infections , 2004, The Lancet.

[51]  A. Rodrigues,et al.  Antifungal activity of local anesthetics against Candida species. , 2000, Infectious diseases in obstetrics and gynecology.

[52]  L. Fricker,et al.  Ring-hydroxylated analogues of lucanthone as antitumor agents. , 1982, Journal of medicinal chemistry.